Mar Barciela-Riveiro - Publications

Corrigendum to "Implementation of anti-HDV reflex testing among HBsAg-positive individuals increases testing for hepatitis D" [JHEP Reports 4 (2022) 100547].

Journal: JHEP reports : innovation in hepatology

Published: August 25, 2026

Corrigendum to: "HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriers" [JHEP Reports 5 (2023) 100842].

Journal: JHEP reports : innovation in hepatology

Published: July 08, 2026

Circulating exhausted CD8+ effector memory cells differentiate immune checkpoint inhibitor-induced liver injury from other acute immune-mediated liver injuries.

Journal: Journal for immunotherapy of cancer

Published: March 06, 2026

Expert consensus on optimal management of liver-related adverse events during CDK4/6 inhibitor therapy.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: March 05, 2026

Clinical features and management for CDK4/6 inhibitor-DILI.

Journal: JHEP reports : innovation in hepatology

Published: January 29, 2026

Clinical features and management for CDK4/6 inhibitor-DILI.

Journal: JHEP reports : innovation in hepatology

Published: January 29, 2026

Baseline HDV-RNA Levels Could Stratify Clinical Risk Before, But Not After, Cirrhosis in Chronic Hepatitis D: A Multicentre European Study.

Journal: Alimentary pharmacology & therapeutics

Published: January 15, 2026

Unveiling pathogens and contaminants: refining metagenomics for clinical diagnostics.

Journal: Frontiers in microbiology

Published: January 13, 2026

Peaked-to-flat transition in quasispecies structure evolution.

Journal: Virus evolution

Published: December 23, 2025

Steatotic Liver Disease at Primary Biliary Cholangitis Diagnosis: Association With Ursodeoxycholic Acid Response and Outcomes.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: November 09, 2025

Current evidence of bulevirtide as monotherapy compared to combination treatment with pegylated interferon for hepatitis delta.

Journal: Expert review of anti-infective therapy

Published: October 24, 2025

Unveiling Drug-Induced Autoimmune-Like Hepatitis in Autoimmune Hepatitis Patients: A Multicenter Retrospective Study.

Journal: Alimentary pharmacology & therapeutics

Published: May 01, 2025